Antara Datta is a prominent inventor based in Piscataway, NJ (US). She has made significant contributions to the field of medical diagnostics, particularly in the detection of bladder cancer. With a total of 5 patents to her name, her work is paving the way for advancements in cancer diagnosis.

Latest Patents

One of her latest patents focuses on the ELISA detection of urine DEK to predict and diagnose bladder cancer in humans. This invention is directed to a method of detecting a DEK protein in a human urine sample using an ELISA assay. The methods and compositions for detection of DEK utilize mAb 260-6F9F6 as the detection antibody and mAb 16-2C9C3 as the capture antibody in human urine. The ELISA assay is designed to yield a high sensitivity of less than 50 ng/mL. The presence of DEK in urine is instrumental in predicting or diagnosing the occurrence of bladder cancer in humans.

Career Highlights

Antara Datta is currently employed at Medical Diagnostic Laboratories, LLC, where she continues to innovate in the field of medical diagnostics. Her work is characterized by a commitment to improving patient outcomes through advanced detection methods.

Collaborations

Antara collaborates with Jason Trama, contributing to the development of groundbreaking diagnostic techniques. Their partnership exemplifies the importance of teamwork in the pursuit of medical advancements.

Conclusion

Antara Datta's contributions to bladder cancer detection through her innovative patents highlight her role as a leading inventor in the medical field. Her work not only enhances diagnostic capabilities but also has the potential to save lives through early detection.